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The correlation between high socioeconomic status (SES) and better survival outcome in patients with
either Hodgkin lymphoma (HL) or non-Hodgkin lymphoma (NHL) was well-established in the pre-
rituximab era. However, whether or not such an association exists in the post-retuxamib era has not
been reliably demonstrated. Herein we conducted a population-based study in Taiwan involving 5010
patients diagnosed between 2002 and 2006 to investigate the relationship between individual and
neighborhood SES and survival outcomes for lymphoma. A proxy measure of individual SES is based on
income-related insurance payment, and neighborhood SES is based on neighborhood household income.
After adjusting for patient characteristics, treatment modalities, and hospital characteristics, HL pa-
tients with high individual SES in advantaged neighborhoods showed a decreased risk of mortality (HR
0.33, 95%, CI 0.10e0.99). NHL patients with high individual SES in advantaged neighborhoods showed a
moderate decreased risk of death (HR 0.62; 95% CI 0.51e0.75), compared to those with low SES in
disadvantaged neighborhoods. In the future, public health strategies and welfare policies must continue
to focus on this vulnerable group.
Copyright © 2016, The Chinese Oncology Society. Production and hosting by Elsevier B.V. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
In Taiwan, hematologic malignancies have become increasingly
prevalent during recent decades,1,2 especially non-Hodgkin lym-
phoma. According to a report from the Taiwan Cancer registry,
more than 80% of non-Hodgkin lymphoma patients suffered from
the B-cell type disease.3 Since its approval by the Taiwan FDA iny-Oncology, Department of
ao Dist., Kaohsiung City 824,
ncology Society.
Society. Production and hosting by2002, rituximab had been the most commonly prescribed drug
used in combination with multi-agent chemotherapy for most pa-
tients with CD20-positive B-cell lymphoma. In the United States,
based upon “real world” investigation, patient survival outcome
signiﬁcantly improved in the post-rituximab era4; yet this new era
has caused moving target-like results when trying to predict the
prognosis of patients with lymphoma. While earlier models relied
mainly on disease character, host character, and biomarker models,
there was a distinct lack of socioeconomic models used to assess
patient survival.5
In the pre-rituximab era, a growing body of literature suggests a
persistent positive relationship existed between socioeconomic
status (SES) and health status, with high SES correlating with better
survival outcome in lymphoma, including Hodgkin and non-Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://
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the post-rituximab era remains unconﬁrmed. SES is thought to
impact cancer survival via various mechanisms, which was brieﬂy
divided into those aspects of disease or host, including but not
limited to delayed diagnosis, differential health-seeking behavior,
access to care, and the presence of co-morbid conditions, among
other factors.10e14 According to a previous study focusing on patient
SES, insurance coverage played an important role in health ineq-
uity. However, universal health coverage in Taiwan might have
eliminated the practice of altering treatment modalities among
patients with different SES.
Otherwise, to limit the proxies of SES, several studies have
explored the combined or cross-level interaction effect of individ-
ual SES and neighborhood SES in several malignancies15e17; how-
ever, several of these studies have shown conﬂicting results.18,19 To
date, there has been no large-scale study which explored the
combined effect of individual and neighborhood SES on lymphoma.
This article describes and compares the overall survival rates
and relative risk of death in patients who were diagnosed with
lymphoma in the post-rituximab era, from 2002 to 2006. We used
the Taiwan National Health Insurance Research Database (NHIRD),
census data, and public information from the Department of Health
to extract individual patient SES and neighborhood SES data. We
used a population-based data set merged with neighborhood SES
information to measure the contextual effect of individual and
neighborhood SES on lymphoma survival rates.
2. Materials and methods
2.1. Ethics statement
This study was initiated after being approved by the Research
Ethical Committee of Buddhist Dalin Tzu Chi General Hospital. All
identifying personal information was removed from the secondary
ﬁles prior to analysis, and the review board agreed to waive the
requirement for written informed consent from the patients
involved.
2.2. Database
The data for this study originated from the NHIRD in Taiwan
between 2002 and 2006. The National Health Insurance Program
enrolls up to 99% of the Taiwanese population and contracts with
97% of Taiwanese medical providers.20,21 The study cohort con-
sisted of patients with lymphoma who began treatment between
2002 and 2006. Lymphoma cases were assigned to one of two
primary diagnostic groups: Hodgkin lymphoma and non-Hodgkin
lymphoma, based on coding numbers from ICD-9 (Hodgkin lym-
phoma: 201, Non - Hodgkin lymphoma: 200 & 202).
2.3. Measurements
We observed that the key dependent variable of interest was the
5-year survival rate. The overall survival ratewas utilized because it
was not possible to determine cause-speciﬁc survival rates based
on this registry data.22 The key independent variables were the
contextual effects of individual SES and neighborhood SES. Patients
were then linked to the mortality data covering the years
2002e2011 to calculate overall survival duration. Each patient was
tracked from his or her ﬁrst curative treatment for a ﬁve-year
period using administrative data to identify all patients who died
during the study period. Patient characteristics included age,
gender, geographic location, treatment modality, severity of co-
morbidity, and monthly income. The severity of co-morbidity of
each patient was based on the modiﬁed Charlson ComorbidityIndex Score (CCIS), which has been widely accepted for risk
adjustment in administrative claims data sets.23
2.4. Individual-level measures
This study used the income-related insurance payment amount
as a proxymeasure of individual SES at the time of diagnosis, which
is an important prognostic factor for cancer.24 By recursive parti-
tioning analysis, we found that NT$ 25000 was an ideal cut-off
point for stratifying our cohort in terms of SES. The cancer pa-
tients were classiﬁed into two groups: 1) low SES: lower than US
$821 (New Taiwan Dollar (NT$) 25000) permonth; and 2) high SES:
US $821 (NT$25001) or more per month, as in our previous
studies.15e17,25
2.5. Neighborhood-level socioeconomic status
For neighborhood SES, household income is a contextual char-
acteristic representing averages and percentages measured at the
enumeration level in the 2001 Taiwan Census. Neighborhood
household income was measured using per capita personal income
by township acquired from the 2001 income tax statistics released
by Taiwan's Ministry of Finance (http://www.fdc.gov.tw/dp.asp?
mp¼5).15 Advantaged and disadvantaged neighborhoods were
identiﬁed based on the median values of neighborhood character-
istics, with advantaged neighborhoods having higher-than-median
neighborhood household incomes, US$ 17900 (or NT $537000), and
disadvantaged neighborhoods having lower-than-median house-
hold incomes.
2.6. Other variables
The urbanization levels of residences were classiﬁed into 7
levels based upon 5 indices: population density, percentage of
residents with college level or higher education, percentage of
residents >65 years of age, percentage of residents who were
agricultural workers, and the number of physicians per 100,000
people.26We recorded the urbanization level of residences as urban
(urbanization level 1), sub-urban (urbanization levels 2e3), or rural
(urbanization levels 4e7).
The hospitals were categorized by ownership (public, nonproﬁt,
or for-proﬁt), and hospital level (medical center, regional or district
hospital). The geographic regions where the cancer patients resided
were recorded as Northern, Central, Southern and Eastern Taiwan.
2.7. Statistical analysis
The SPSS program (version 15, SPSS Inc., Chicago, IL, USA) was
used for data analysis. Pearson's chi-square test was used for cat-
egorical variables such as gender, level of urbanization, geographic
region of residence, CCIS, treatment modality, and hospital char-
acteristics, and continuous variables were analyzed with one-way
ANOVA.
The cumulative 5-year survival rates and the survival curves
were constructed and compared using the log-rank test. Survival
curves, stratiﬁed by individual SES and neighborhood SES, were
measured from the time of diagnosis by using overall mortality as
the event variable. The Cox proportional hazards regression model
adjusted for patients' characteristics (age, gender, CCIS, urbaniza-
tion and area of residence), treatment modality and hospital char-
acteristics, was used to compare outcomes between different SES
categories. SES variables were introduced into the Cox model, with
the high individual SES and advantaged neighborhood group as the
reference group. A two-tailed P-value (P < 0.05) was used to
determine statistical signiﬁcance.
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3.1. Demographic data and clinical characteristics
A total of 5010 lymphoma patients who received treatment
were included in the study (Table 1), wherein 497 patients were
diagnosed with Hodgkin lymphoma and 4513 with non-Hodgkin
lymphoma.
Hodgkin lymphoma patients of low individual SES were more
likely to reside in rural areas, speciﬁcally in southern and eastern
Taiwan, and had higher Charlson Comorbidity index scores
compared to patients with high individual SES. Patients of both low
and high SES underwent treatment equally at regional and district
hospitals, and there were no statistical differences in treatment
modality.
For non-Hodgkin lymphoma, patients with low SES were more
likely to be female and older and to have higher Charlson Comor-
bidity index scores, reside in rural areas, speciﬁcally in southern
and eastern Taiwan, and to have undergone treatment at regional
and district hospitals.3.2. Survival analysis
The overall survival of patients with lymphoma who have
different levels of socioeconomic status was analyzed (Table 2). For
patients with HL, those with high individual SES in advantaged or
disadvantaged neighborhoods were more likely to have higher 5-
year overall survival rates than patients with low individual SES
(95.7% and 96.6%, respectively, versus 78.1% and 75.8%, respectively,
where P < 0.001) (Fig. 1). For patients with NHL, those with high
individual SES and high neighborhood SES weremore likely to have
higher 5-year overall survival rates than patients with low indi-
vidual and neighborhood SES (72.1% versus 49.5%, respectively,
where P < 0.001) (Fig. 2).Table 1
Demographics of patients with Hodgkin lymphoma/non-Hodgkin lymphoma between 2
Variables Hodgkin lymphoma (n ¼ 497)
High SES Low SES
(n ¼ 123) (n ¼ 374)
Mean age, years (±SD) 34 ± 12 37 ± 22
Gender
Male 75 (61.0) 217 (58.0)
Female 48 (39.0) 157 (42.0)
Urbanization
Urban 43 (35.0) 87 (23.3)
Suburban 70 (56.9) 173 (46.3)
Rural 10 (8.1) 114 (30.5)
Geographic Region
Northern 89 (72.4) 186 (49.7)
Central 10 (8.1) 70 (18.7)
Southern/Eastern 24 (19.5) 118 (31.6)
Charlson Comorbidity Index Score
0 76 (61.8) 183 (48.9)
1e6 46 (37.4) 178 (47.6)
>6 1 (0.8) 13 (3.5)
Treatment modality
Radiotherapy 2 (1.6) 12 (3.2)
Chemotherapy 75 (61.0) 230 (61.5)
Chemotherapy plus radiotherapy 46 (37.4) 132 (35.3)
Hospital characteristics teaching level
Medical center 99 (80.5) 291 (77.8)
Regional 22 (17.9) 77 (20.6)
District 2 (1.6) 6 (1.6)
Abbreviation: SES, socioeconomic status.3.3. Multivariable survival analysis
The combined effects of individual SES and neighborhood SES
remained statistically signiﬁcant in the Cox proportional hazards
regression model, when adjusted for other factors in patients with
both HL and NHL. Patients with HL with high individual SES in
advantaged neighborhoods showed a large decrease in the risk of
mortality (HR 0.33, 95% CI 0.10e0.99) (Table 3). Among patients
with NHL, those with high individual SES in advantaged neigh-
borhoods showed a decreased risk of death (HR 0.62; 95% CI
0.51e0.75), compared with those with low SES in disadvantaged
neighborhood.
4. Discussion
To the best of our knowledge, there have been limited studies
about the socioeconomic status of patients with lymphoma in the
post-rituximab era, including studies concerning the combined
effects of individual and neighborhood socioeconomic gradients in
lymphoma. In our study, we described that for patients with HL or
NHL, the combined effects of individual and neighborhood SES
resulted in a moderate decrease in the risk of overall mortality
despite universal health coverage in the post-rituximab era. There
was a synchronous effect of combined individual and neighbor-
hood SES in predicting overall survival in lymphoma patients,
especially for those with non-Hodgkin lymphoma.
Our study had a number of strengths. First, it was a large
nationwide population-based follow-up study, with nearly com-
plete follow-up information about access to healthcare institutions
by the entire study population (99%). The dataset was also routinely
monitored for diagnostic accuracy by the National Health Insurance
Bureau of Taiwan.21 Therefore, the data set was more generalized
and truly reﬂected clinical practice in the real world, with minimal
selection bias. Second, a large majority of the earlier research
studied SES in patients aged 65 and older, before the era of ritux-
imab, or in speciﬁc categories, just like patients with Hodgkin002 and 2006 in Taiwan (n ¼ 5010).
Non-Hodgkin lymphoma (n ¼ 4513)
P-value High SES Low SES P-value
(n ¼ 849) (n ¼ 3664)
0.194 47 ± 16 60 ± 18 <0.001
0.564 <0.001
568 (66.9) 2080 (56.8)
281 (33.1) 1584 (43.2)
<0.001 <0.001
323 (38.0) 903 (24.6)
413 (48.6) 1533 (41.8)
113 (13.3) 1228 (33.5)
<0.001 <0.001
495 (58.3) 1681 (45.9)
126 (14.8) 692 (18.9)
228 (26.9) 1291 (35.2)
0.025 0.013
381 (44.9) 1452 (39.6)
430 (50.6) 2002 (54.6)
38 (4.5) 210 (5.7)
0.625 0.033
37 (4.4) 231 (6.3)
575 (67.7) 2518 (68.7)
237 (27.9) 915 (25.0)
0.809 0.006
659 (77.6) 2683 (73.2)
177 (20.8) 868 (23.7)
13 (1.5) 113 (3.1)
Table 2
Combined effect of individual SES and neighborhood SES on 5-year overall survival rates (n ¼ 5010).
Neighborhood socioeconomic
status
Individual socioeconomic status
Hodgkin lymphoma (n ¼ 497) Non-Hodgkin lymphoma (n ¼ 4513)
High SES Low SES P-value High SES Low SES P-value
(n ¼ 123) (n ¼ 374) (n ¼ 849) (n ¼ 3664)
<0.001 <0.001
Advantaged (n ¼ 2532) 90 (95.7) 150 (78.1) 398 (72.1) 914 (54.0)
Disadvantaged (n ¼ 2478) 28 (96.6) 138 (75.8) 204 (68.7) 975 (49.5)
Abbreviation: Adjusted HR, adjusted hazard ratio; 95% CI, 95% conﬁdence interval; SES, socioeconomic status.
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in a cohort of the overall population. Our series didn't have any
limitation in age and disease entity. Third, we focused on the role of
SES and lymphoma survival in the post-rituximab era, and the re-
sults deﬁnitely reﬂected the real world circumstances of our cur-
rent practice. Fourth, the combined effects of individual and
neighborhood SES might eliminate the ordinary limitation of each
proxy. We observed the prominent effects of combined SES on the
overall survival of patients with lymphoma, and the result was not
conﬂict between different proxies.
For HL, most previous studies have shown a correlation between
decreasing survival rates for patients with HL with decreasing
SES,6e8 although several studies found no or a varied association
between survival outcomes in patients with HL with decreasing
SES.13,27 The differences in these ﬁndings may be attributable to
different health care systems or area-based markers of SES. In our
study, however, we demonstrated a similar result, suggesting that
low SES predicted poor overall survival in the last decade.
For NHL, rituximab played an important role in the ﬁeld of
treatment of CD20-positive B cell lymphoma in recent decades, and
has profoundly altered the manner in which this disease is treated.Fig. 1. SES, neighborhoods and 5-year OS in HL patients. Those with high individual
SES in advantaged or disadvantaged neighborhoods were more likely to have higher 5-
year overall survival rates than patients with low individual SES (95.7% and 96.6%
versus 78.1% and 75.8%, P < 0.001).Although low SES was correlated with poorer survival outcome
after diagnosis of NHL in the pre-rituximab era despite universal
health coverage among Canadian adults,28 the association remains
unclear in the post-rituximab era. We demonstrated that a low
combined SES score correlated with poor survival outcome, even in
the post-rituximab era.
There have been many hypothesis presented attempting to
explain why lower SES predicted low survival outcome, including
the state of advanced disease upon initial diagnosis,11,14 receipt of
poorer cancer treatment,9,29,30 inadequate health insurance,6,31
lower complete response, increased fatal events during treat-
ment,8 or inadequate long-term follow-up in patients. Personal
factors may also contribute to reduced survival, similar to smoking
related poorer health status and co-morbidity among cancer pa-
tients with various SES,10,12,13 nutritional status-related inﬂuence
in treatment tolerance and survival sequentially,32 and male
gender for more advanced disease at the time of diagnosis.33,34 In
Taiwan, universal health coverage may have eliminated the impact
of the medical factor, better equalizing treatment modalities
among patients with different SES. However, the inequality of
health status among these patients still existed. This suggests thatFig. 2. SES, neighborhoods and 5-year OS in NHL patients. Those with high individual
SES and high neighborhood SES were more likely to have higher 5-year overall survival
rates than patients with low individual and neighborhood SES (72.1% versus 49.5%,
P < 0.001).
Table 3
Hazard ratios of individual SES for mortality in advantaged and disadvantaged neighborhoodsa (n ¼ 5010).
Neighborhood socioeconomic
status
Individual socioeconomic status
Hodgkin lymphoma (n ¼ 497) Non-Hodgkin lymphoma (n ¼ 4513)
High SES Low SES High SES Low SES
Adjusted HR 95% CI Adjusted HR 95% CI Adjusted HR 95% CI Adjusted HR 95% CI
Advantaged 0.33 (0.10e0.99) 1.48 (0.85e2.59) 0.62 (0.51e0.75) 0.92 (083e1.03)
Disadvantaged 0.22 (0.03e1.69) 1 0.67 (0.54e0.84) 1
Abbreviation: Adjusted HR, adjusted hazard ratio; 95% CI, 95% conﬁdence interval; SES, socioeconomic status.
a Adjusted for the patients' diagnosed age, gender, Charlson Comorbidity Index Score.
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outcome.
Although individual measures have been shown to be more
strongly associated with health outcomes than neighborhood
measures,35,36 neighborhood SES may inﬂuence health through the
social, environmental, and physical environments of the neigh-
borhood.36,37 Besides individual SES, neighborhood SES inﬂuenced
mortality and other outcomes.38,39 Some studies controlling for
both types of SES measures have found effects on health of
neighborhood SES above and beyond those attributable to indi-
vidual SES.36,37 Because disease outcome was contributed by many
individual and neighborhood alteration factor, it shouldmake sense
when both factors are taken into consideration. The impact of the
cross-level interaction of individual SES and neighborhood SES was
various in several malignancies.40 In our team, we had demon-
strated the combined effect of individual and neighborhood SES in
survival outcome in nasopharyngeal cancer, breast cancer, and lung
cancer.15e17 Regarding our study, synchronous effect was docu-
mented such that high combined individual and neighborhood SES
was correlated with better survival outcome in lymphoma, espe-
cially in non-Hodgkin type.
There were some limitations to our study. First, there was po-
tential for misclassiﬁcation in the diagnosis of cancer and any co-
morbid conditions which were completely dependent on ICD
codes. Nonetheless, the National Health Insurance Bureau of
Taiwan randomly reviews the charts and interviews patients in
order to verify diagnostic accuracy.21 Second, the database does not
contain information on potentially relevant clinical data such as
performance status or biochemical laboratory examinations. Our
study could not estimate the impact of these factors on survival.
Third, detailed clinical information about grade, stage, and histo-
logical subtypes of lymphomas were not included in the dataset;
however, previous studies have revealed no statistically signiﬁcant
associations between SES and tumor stage at the time of diagnosis
in several malignancies, including Hodgkin lymphoma and follic-
ular lymphoma7,41 and no signiﬁcant association was found be-
tween SES and histological subgroups.11 Fourth, SES includes
several factors, such as income, education, and occupation. Among
them, income is frequently used as a surrogate for SES. In our study,
since the information of education and occupation was not
included in the database from NHIRD in Taiwan, we used income as
the surrogate for SES.5. Conclusions
The results of our study indicated that, in Taiwan, there were
health inequities for both Hodgkin and non-Hodgkin lymphoma as
a result of a combination of individual and neighborhood SES, even
within a system of universal health insurance in the post-rituximab
era. Elucidation of the relative roles of these factors could guide
interventions in the future, to reduce disparities in survival. The
ﬁnding of social inequity in lymphoma patients could be addressedin clinical practice if general practitioners paid special attention to
patients of low SES. Public health strategies should also focus on
patients with low individual and neighbor SES in order to reduce
disparities in healthcare.
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